Literature DB >> 35751779

Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Marta Araujo-Castro1,2,3, César Mínguez Ojeda4, María Noelia Sánchez Ramírez5, Victoria Gómez Dos Santos4, Eider Pascual-Corrrales5, María Fernández-Argüeso5.   

Abstract

PURPOSE: To compare the evolution of the cardiometabolic parameters in patients with nonfunctioning adrenal incidentalomas (NFAI) and autonomous cortisol secretion (ACS) who underwent adrenalectomy and those who were conservatively managed.
METHODS: A retrospective study of all patients with NFAI and ACS submitted to surgery or in follow-up in our center between January 2011-October 2020. NFAI was defined as an adrenal incidentaloma with cortisol post-dexamethasone suppression test (DST) ≤ 50 nmol/L and ACS as values >50 nmol/L without specific clinical signs of overt Cushing´s syndrome.
RESULTS: A total of 486 patients with NFAI (16 in the surgical group and 470 in the control group) and 259 with ACS (42 in the surgical group and 217 in the control group) were included. At baseline, patients with ACS were older than those with NFAI (P = 0.010). After adjusting by age, patients with ACS had a higher prevalence of hypertension (adjusted OR = 1.9 [1.36-2.60]) and higher levels of fasting plasma glucose and HbA1c (adjusted β = 6.9 [2.05-11.83] and adjusted β = 0.4 [0.12-0.63]) than NFAI. During follow-up, ACS patients who underwent adrenalectomy had a greater decrease in glucose levels (-16.6 ± 45.07 vs. -1.0 ± 26.92 mg/dL, P = 0.035) and in triglycerides (-20.21 ± 55.97 vs. 1.3 ± 59.23 mg/dL, P = 0.029) than ACS patients conservatively managed. NFAI patients who underwent surgery experienced an improvement in systolic blood pressure compared to NFAI of the conservative group (-11.1 ± 15.94 vs 1.0 ± 17.54 mmHg, P = 0.009).
CONCLUSION: The benefits of adrenalectomy in the cardiometabolic profile in adrenal incidentalomas are not limited only to the group of patients with ACS, an improvement in blood pressure control is also observed in NFAI patients after surgery.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adrenal incidentaloma; Adrenalectomy; Autonomous cortisol secretion; Mild hypercortisolism; Nonfunctioning adrenal incidentaloma

Mesh:

Substances:

Year:  2022        PMID: 35751779     DOI: 10.1007/s12020-022-03120-w

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  34 in total

1.  Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.

Authors:  Guido Di Dalmazi; Valentina Vicennati; Eleonora Rinaldi; Antonio Maria Morselli-Labate; Emanuela Giampalma; Cristina Mosconi; Uberto Pagotto; Renato Pasquali
Journal:  Eur J Endocrinol       Date:  2012-01-20       Impact factor: 6.664

2.  Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.

Authors:  Luigi Petramala; Giuseppe Cavallaro; Matteo Galassi; Cristiano Marinelli; Gianfranco Tonnarini; Antonio Concistrè; Umberto Costi; Maurizio Bufi; Piernatale Lucia; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-01-31

3.  Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

Authors:  Iacopo Chiodini; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Massimo Torlontano; Francesca Coletti; Laura Iorio; Antonello Cuttitta; Angelo Ambrosio; Leonardo Vicentini; Fabio Pellegrini; Massimiliano Copetti; Paolo Beck-Peccoz; Maura Arosio; Bruno Ambrosi; Vincenzo Trischitta; Alfredo Scillitani
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

4.  Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis.

Authors:  Fani Athanasouli; Georgios Georgiopoulos; Nikos Asonitis; Fotini Petychaki; Akrivi Savelli; Evangelia Panou; Anna Angelousi
Journal:  Endocrine       Date:  2021-05-07       Impact factor: 3.633

5.  Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?

Authors:  Melpomeni Peppa; Eleni Boutati; Chrysi Koliaki; Nasos Papaefstathiou; Efstathios Garoflos; Theofanis Economopoulos; Dimitrios Hadjidakis; Sotirios A Raptis
Journal:  Metabolism       Date:  2010-02-13       Impact factor: 8.694

6.  Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas.

Authors:  H Yilmaz; N B Tütüncü; M Sahin
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

7.  Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study.

Authors:  Antonio Toniato; Isabella Merante-Boschin; Giuseppe Opocher; Maria R Pelizzo; Francesca Schiavi; Enzo Ballotta
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

Review 8.  Subclinical Hypercortisolism: How to Deal with It?

Authors:  Iacopo Chiodini; Valentina Morelli
Journal:  Front Horm Res       Date:  2016-05-17       Impact factor: 2.606

9.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

Review 10.  THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis.

Authors:  Irina Bancos; Fares Alahdab; Rachel K Crowley; Vasileios Chortis; Danae A Delivanis; Dana Erickson; Neena Natt; Massimo Terzolo; Wiebke Arlt; William F Young; M Hassan Murad
Journal:  Eur J Endocrinol       Date:  2016-07-22       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.